A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and <i>In Silico</i> Verification.
Journal Information
Full Title: Evid Based Complement Alternat Med
Abbreviation: Evid Based Complement Alternat Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Integrative & Complementary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability all the results used to support this work are included in the article. more details were deposited in the science data bank (doi"
"Conflicts of Interest The authors declare that there are no conflicts of interest."
"This work was supported by the Collaborative Innovation Research and High-Level Team Building of Integrated Chinese and Western Medicine in Diagnosis and Treatment of Malignant Tumors (No. 2021XK09), the Basic Theoretical Research of Chinese Medicine of the Guangzhou University of Chinese Medicine (Jiebang Guashuai Lizhu Lin project, No. Project [2022]-7), the Cooperative Research of High-Level Hospital Project (Lung Cancer) (2019–2022), the National Natural Science Foundation of China (No. 82104647 and No. 81973775), and the Postdoctoral Science Foundation of China (No. 2021M700964). The authors thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025